3billion
G-NIPT® Basic
Screening for trisomy 21, 18, and 13; sex chromosome aneuploidies; fetal sex confirmation; and other autosomal trisomies.
Specimen: Streck cfDNA tube
TAT: 10–12 days
Clinical Area · NIPT & Prenatal
Non-invasive prenatal screening from maternal blood
NIPT analyses cell-free fetal DNA circulating in maternal blood from as early as 10 weeks of gestation. It is a screening test — not diagnostic — and results should be interpreted by the ordering clinician in the context of the pregnancy.
NIPT is a screening test and does not replace diagnostic testing such as amniocentesis or CVS. A positive or high-risk result requires confirmatory diagnostic evaluation before clinical decisions are made.
What NIPT screens for
Core trisomy screening
Trisomy 21 (Down syndrome), trisomy 18 (Edwards), and trisomy 13 (Patau) — the three most clinically significant autosomal trisomies.
Sex chromosome aneuploidies
Conditions such as Turner syndrome (45,X), Klinefelter syndrome (47,XXY), and other sex chromosome variations.
Fetal sex determination
Available as part of most NIPT panels. Useful for X-linked disease risk assessment or parental information.
Expanded coverage
Premium panels cover additional autosomal trisomies, selected CNVs, and microdeletion/microduplication syndromes.
Pathogen screening
Selected panels include a focused maternal pathogen screen alongside chromosomal analysis.
Available panels
NIPT options through Advanced Consensus
Multiple NIPT panel options are available from 3billion and GC Genome, differing in chromosomal coverage and sample requirements. The ordering physician selects the appropriate panel for the clinical indication.
3billion
G-NIPT® Lite
Core non-invasive prenatal screening for trisomy 21, 18, and 13, sex chromosome aneuploidies, and fetal sex confirmation.
Specimen: Streck cfDNA tube
TAT: 10–12 days
3billion
G-NIPT® Premium
Expanded NIPT covering all autosomes, sex chromosome aneuploidies, fetal sex, selected CNVs, and CNVs larger than 7 Mb.
Specimen: Streck cfDNA tube
TAT: 10–12 days
GC Genome
i-screen®
Non-invasive prenatal screening option performed from maternal EDTA whole blood.
Specimen: EDTA whole blood
TAT: 10–12 days
GC Genome
NICE® Premium + Pathogen
Expanded NIPT with all autosomes, sex chromosome aneuploidies, 143 microdeletions, fetal sex, and a focused pathogen panel.
Specimen: Streck cfDNA tube
TAT: 10–12 days
NIPT & prenatal
Order NIPT for your patient
For obstetricians, gynecologists, and maternal-fetal medicine specialists. Share the gestational age, clinical indication, and any prior screening results.
Suite 403, 133 Madina Munawara St, Amman, Jordan
+962 791 707 606 info@advancedconsensus.comMessage us on WhatsAppFor website inquiries, avoid patient names, national IDs, medical record numbers, or reports. Secure document exchange should happen through approved clinical channels.